版本:
中国

BRIEF-Insys Therapeutics Drug Enforcement Agency issued an interim final rule

March 23 Insys Therapeutics Inc:

* Insys Therapeutics-drug enforcement agency issued interim final rule that would result in syndros being placed in schedule II of Controlled Substances Act

* Insys Therapeutics Inc - "look forward to interacting with FDA to finalize labeling and subsequent launch of Syndros in second half of 2017" Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐